Stock listing
A2PREX Stock Price, News, Filings & Events — Aim Immunotech Inc.
Selected listing: A2PREX · LSX · EUR · DE
This page tracks Aim Immunotech Inc.'s A2PREX:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A2PREX:LSX. A2PREX:LSX is the stock-level entry point for investors researching Aim Immunotech Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- A2PREX:LSX
- Asset type
- Stock
- Market cap
- $6.7M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- LSX
- Currency
- EUR
Aim Immunotech Inc. A2PREX:LSX stock context
This page tracks Aim Immunotech Inc.'s A2PREX:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A2PREX:LSX. A2PREX:LSX is the stock-level entry point for investors researching Aim Immunotech Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Aim Immunotech Inc.
AIM ImmunoTech Reports Second Quarter 2026 Financial Results and Highlights Significant Operational Execution Advancing Ampligen(R) Towar...
August 11, 2026
AIM ImmunoTech Reports Second Quarter 2026 Financial Results and Highlights Significant Operational Execution Advancing Ampligen® Toward ...
August 10, 2026
AIM ImmunoTech Regains NYSE American Compliance, Company Resolves Stockholder Equity Deficiency
June 15, 2026
AIM ImmunoTech Announces $2.65 Million Financing Priced At-Market under NYSE American Rules
June 9, 2026
AIM ImmunoTech Reports Positive Mid-Year Interim Clinical Progress from Phase 2 Study Evaluating Ampligen® (rintatolimod) in Combination ...
June 8, 2026
Aim Immunotech Inc. earnings calls
AIM ImmunoTech Inc. (AIM) Q2 2025 Earnings Call
August 20, 2025 · Replay with transcript and chapters
AIM ImmunoTech Inc. (AIM) Q4 2024 Earnings Call
April 1, 2025 · Replay with transcript and chapters
AIM ImmunoTech Inc. (AIM) Q3 2024 Earnings Call
November 15, 2024 · Replay with transcript and chapters
AIM ImmunoTech Inc. (AIM) Q2 2024 Earnings Call
August 16, 2024 · Replay with transcript and chapters
AIM ImmunoTech Inc. (AIM) Q1 2024 Earnings Call
May 16, 2024 · Replay with transcript and chapters
AIM ImmunoTech Inc. (AIM) Q4 2023 Earnings Call
April 2, 2024 · Replay with transcript and chapters
Research Aim Immunotech Inc.
Aim Immunotech Inc. investor report
Review AI stock analysis and investor report context for A2PREX:LSX.
Aim Immunotech Inc. company profile
View the public company page for Aim Immunotech Inc. on 6ix.
Aim Immunotech Inc. news
Read company news and market updates connected to Aim Immunotech Inc..
Aim Immunotech Inc. investor events
Find investor webinars, events, and replay context for Aim Immunotech Inc..
Alternate listings
AIM:AMEX
US · USD
Alternate listing for Aim Immunotech Inc.; the primary context on this page is A2PREX:LSX.
AIM:BOATS
US · USD
Alternate listing for Aim Immunotech Inc.; the primary context on this page is A2PREX:LSX.
0A4Y:LSE
GB · USD
Alternate listing for Aim Immunotech Inc.; the primary context on this page is A2PREX:LSX.
HXB:GETTEX
DE · EUR
Alternate listing for Aim Immunotech Inc.; the primary context on this page is A2PREX:LSX.
HXB:FWB
DE · EUR
Alternate listing for Aim Immunotech Inc.; the primary context on this page is A2PREX:LSX.
A2PREX:LS
DE · EUR
Alternate listing for Aim Immunotech Inc.; the primary context on this page is A2PREX:LSX.
A416YS:LS
DE · EUR
Alternate listing for Aim Immunotech Inc.; the primary context on this page is A2PREX:LSX.
A416YS:LSX
DE · EUR
Alternate listing for Aim Immunotech Inc.; the primary context on this page is A2PREX:LSX.
HXB:MUN
DE · EUR
Alternate listing for Aim Immunotech Inc.; the primary context on this page is A2PREX:LSX.